Table 6. 30-day avoidable healthcare cost of patients hospitalized with altered mental status attributable to high gabapentin dose.
Prevalence of Patients Receiving High Dose Gabapentin | Gabapentin Cost& | Emergency Department Cost& | Hospitalization Cost& | Total Healthcare Cost& | 30 Day Healthcare Cost Avoidable by Using Low Dose# Gabapentin |
---|---|---|---|---|---|
31%$ | $3,697.02 | $91,241.52 | $994,291.06 | $1,123,281.82 | --- |
23.3% (25% reduction) | $2,836.85 | $70,012.73 | $762,953.47 | $861,932.48 | $261,349/34 |
15.5% (50% reduction) | $1,928.03 | $47,583.20 | $518,530.95 | $585,800.69 | $537,481.13 |
7.8% (75% reduction) | $991.42 | $24,467.96 | $266,636.02 | $301,227.08 | $822,054.74 |
0% (100% reduction)* | --- | --- | --- | --- | $1,123,281.82 |
&Attributable cost to high gabapentin dose in patients hospitalized with altered mental status.
#Low dose as described in this study as ≤600mg per day of gabapentin.
$ Actual proportion of patients in our cohort who were initiated on a high dose gabapentin (>600mg per day)
*100% reduction of patients receiving high dose gabapentin = all patients receive low dose.